ClinicalTrials.Veeva

Menu

Somesthesic Role of the Ventro-lateral Prefrontal Cortex in Speech Motor Learning (BRAVA²)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Completed

Conditions

Speech
Motor Activity

Treatments

Behavioral: Speech adaptation
Behavioral: Vibrotactile Discrimination
Other: fMRI
Behavioral: Speech production

Study type

Interventional

Funder types

Other

Identifiers

NCT04547569
38RC18.173

Details and patient eligibility

About

These studies test the hypothesis that frontal areas of the brain participate in the cortical networks involved in the somotosensory processing that happens during speech motor learning.

Full description

This work aims to study the role of sensory systems in human motor learning and specifically addresses the involvement of somatosensory cortical networks in motor learning of speech. Previous studies in the literature have highlighted the plasticity of cortical sensory networks, notably the primary and secondary somatosensory cortex and the ventral premotor cortex, during motor learning tasks. The present project focuses on the somatosensory region with connections to the sensorimotor regions of the frontal and parietal cortex. We propose to use neuroimaging (fMRI), in order to verify which areas in the prefrontal cortex are part of the sensorimotor network used in the learning of speech motor tasks in humans. Subjects will be tested in the fMRI scanner while performing either a behavioral task in which the auditory feedback of their own speech is altered or while performing a vibrotactile discrimination task.

Enrollment

16 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Right-handed subjects
  • Subjects fluent in French
  • Signed informed consent
  • Affiliation to or beneficiary of a Social Security scheme

Exclusion criteria

  • Left-handed subjects

  • Criteria for contraindications to protocol fMRI scans

  • Existence of a severe general condition: cardiac, respiratory, hematological, renal, hepatic, cancerous.

  • Hearing, language (including dyslexia), neurological or psychiatric disorders.

  • Participation in other ongoing intervention research protocols with exclusionary period or within the previous week

  • Drug treatment likely to modulate brain activity: benzodiazepines, antidepressants, neuroleptics, lithium, etc.

  • Protected persons referred to in articles L1121 5 to L1121 8 of the French CSP:

    • Pregnant women, parturients, nursing mothers,
    • Persons deprived of liberty by a judicial or administrative decision,
    • Persons under psychiatric care,
    • Individuals admitted to a health or social institution for purposes other than research,
    • Minors,
    • Persons over the age of majority who are subject to a legal protection measure or who are unable to express their consent

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

16 participants in 3 patient groups

Adaptation to altered auditory feedback
Experimental group
Description:
fMRI measurement of brain activity during speech production under altered auditory feedback
Treatment:
Other: fMRI
Behavioral: Speech adaptation
Speech production
Experimental group
Description:
fMRI measurement of brain activity during normal speech production
Treatment:
Other: fMRI
Behavioral: Speech production
Vibrotactile discrimination
Experimental group
Description:
fMRI measurement of brain activity during a vibrotactile discrimination task
Treatment:
Behavioral: Vibrotactile Discrimination
Other: fMRI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems